AAPL343.75+1.75 (+0.51%) ▲|ABBV284.01+0.66 (+0.23%) ▲|ABT105.38+0.70 (+0.67%) ▲|ACN225.52+0.60 (+0.27%) ▲|ADBE249.76-1.91 (-0.76%) ▼|AMAT421.43-8.58 (-2.00%) ▼|AMD542.63-19.61 (-3.49%) ▼|AMGN437.85+3.82 (+0.88%) ▲|AMT183.39+2.03 (+1.12%) ▲|AMZN253.21-1.55 (-0.61%) ▼|AVGO338.43-5.91 (-1.71%) ▼|AXP319.10+5.23 (+1.67%) ▲|BA191.52+2.79 (+1.48%) ▲|BAC52.32+0.62 (+1.20%) ▲|BKNG166.32+0.52 (+0.31%) ▲|BLK1,139.18+18.40 (+1.64%) ▲|BMY60.81+0.24 (+0.39%) ▲|BNY143.80+1.71 (+1.20%) ▲|BRK-B531.42+5.74 (+1.09%) ▲|C125.85+2.64 (+2.14%) ▲|CAT738.06+2.42 (+0.33%) ▲|CL93.65+0.98 (+1.06%) ▲|CMCSA22.08+0.31 (+1.42%) ▲|COF203.55+4.69 (+2.36%) ▲|COP144.26+2.53 (+1.79%) ▲|COST987.72+9.71 (+0.99%) ▲|CRM241.89-4.85 (-1.97%) ▼|CSCO108.03-1.82 (-1.66%) ▼|CVS93.09+0.51 (+0.55%) ▲|CVX222.46+3.14 (+1.43%) ▲|DE649.95-0.73 (-0.11%) ▼|DHR229.74-1.76 (-0.76%) ▼|DIS111.50+0.82 (+0.74%) ▲|DUK120.54+1.66 (+1.39%) ▲|EMR162.67+0.52 (+0.32%) ▲|FDX297.57+2.03 (+0.69%) ▲|GD344.02+6.99 (+2.07%) ▲|GE319.62+7.62 (+2.44%) ▲|GEV933.59+7.15 (+0.77%) ▲|GILD156.90-0.47 (-0.30%) ▼|GM85.23+1.57 (+1.88%) ▲|GOOG340.26-4.65 (-1.35%) ▼|GOOGL344.13-5.09 (-1.46%) ▼|GS899.30+8.02 (+0.90%) ▲|HD312.61+4.37 (+1.42%) ▲|HON211.78+1.28 (+0.61%) ▲|IBM233.52-0.60 (-0.26%) ▼|INTC92.34-3.03 (-3.18%) ▼|INTU326.59-3.58 (-1.08%) ▼|ISRG433.29+5.43 (+1.27%) ▲|JNJ257.34+4.06 (+1.60%) ▲|JPM342.06+6.53 (+1.95%) ▲|KO93.37+1.37 (+1.48%) ▲|LIN500.24+7.02 (+1.42%) ▲|LLY1,265.23+13.62 (+1.09%) ▲|LMT546.01+13.37 (+2.51%) ▲|LOW198.43+2.71 (+1.38%) ▲|LRCX270.92-6.55 (-2.36%) ▼|MA620.09+3.77 (+0.61%) ▲|MCD243.80+1.30 (+0.53%) ▲|MDLZ64.06+1.03 (+1.63%) ▲|MDT95.63+0.18 (+0.19%) ▲|META726.33-10.39 (-1.41%) ▼|MMM167.05+1.72 (+1.04%) ▲|MO74.86+1.02 (+1.38%) ▲|MRK147.21+2.02 (+1.39%) ▲|MS182.90+0.80 (+0.44%) ▲|MSFT535.99-3.45 (-0.64%) ▼|MU893.37-37.87 (-4.07%) ▼|NEE80.08+1.12 (+1.42%) ▲|NFLX71.06-1.56 (-2.14%) ▼|NKE37.61+0.47 (+1.27%) ▲|NOW145.95-2.63 (-1.77%) ▼|NVDA216.23-1.00 (-0.46%) ▼|ORCL131.80-2.67 (-1.99%) ▼|PEP130.37+1.99 (+1.55%) ▲|PFE29.56+0.12 (+0.41%) ▲|PG159.63+2.55 (+1.62%) ▲|PLTR194.95-5.55 (-2.77%) ▼|PM204.33+4.43 (+2.21%) ▲|QCOM174.35-4.05 (-2.27%) ▼|RTX190.95+4.00 (+2.14%) ▲|SBUX97.01+0.13 (+0.13%) ▲|SCHW93.83-0.33 (-0.35%) ▼|SO90.12+0.94 (+1.05%) ▲|SPG205.58+2.19 (+1.08%) ▲|T23.56+0.06 (+0.23%) ▲|TMO691.51-4.98 (-0.72%) ▼|TMUS158.75+1.72 (+1.10%) ▲|TSLA366.61+4.17 (+1.15%) ▲|TXN280.91+1.79 (+0.64%) ▲|UBER71.22-0.05 (-0.07%) ▼|UNH397.50-9.17 (-2.25%) ▼|UNP289.48+0.77 (+0.27%) ▲|UPS99.15+1.32 (+1.35%) ▲|USB58.62+1.23 (+2.13%) ▲|V403.07+3.32 (+0.83%) ▲|VZ44.66+0.26 (+0.57%) ▲|WFC84.08+1.33 (+1.61%) ▲|WMT118.83+0.96 (+0.81%) ▲|XOM175.92+1.24 (+0.71%) ▲|AAPL343.75+1.75 (+0.51%) ▲|ABBV284.01+0.66 (+0.23%) ▲|ABT105.38+0.70 (+0.67%) ▲|ACN225.52+0.60 (+0.27%) ▲|ADBE249.76-1.91 (-0.76%) ▼|AMAT421.43-8.58 (-2.00%) ▼|AMD542.63-19.61 (-3.49%) ▼|AMGN437.85+3.82 (+0.88%) ▲|AMT183.39+2.03 (+1.12%) ▲|AMZN253.21-1.55 (-0.61%) ▼|AVGO338.43-5.91 (-1.71%) ▼|AXP319.10+5.23 (+1.67%) ▲|BA191.52+2.79 (+1.48%) ▲|BAC52.32+0.62 (+1.20%) ▲|BKNG166.32+0.52 (+0.31%) ▲|BLK1,139.18+18.40 (+1.64%) ▲|BMY60.81+0.24 (+0.39%) ▲|BNY143.80+1.71 (+1.20%) ▲|BRK-B531.42+5.74 (+1.09%) ▲|C125.85+2.64 (+2.14%) ▲|CAT738.06+2.42 (+0.33%) ▲|CL93.65+0.98 (+1.06%) ▲|CMCSA22.08+0.31 (+1.42%) ▲|COF203.55+4.69 (+2.36%) ▲|COP144.26+2.53 (+1.79%) ▲|COST987.72+9.71 (+0.99%) ▲|CRM241.89-4.85 (-1.97%) ▼|CSCO108.03-1.82 (-1.66%) ▼|CVS93.09+0.51 (+0.55%) ▲|CVX222.46+3.14 (+1.43%) ▲|DE649.95-0.73 (-0.11%) ▼|DHR229.74-1.76 (-0.76%) ▼|DIS111.50+0.82 (+0.74%) ▲|DUK120.54+1.66 (+1.39%) ▲|EMR162.67+0.52 (+0.32%) ▲|FDX297.57+2.03 (+0.69%) ▲|GD344.02+6.99 (+2.07%) ▲|GE319.62+7.62 (+2.44%) ▲|GEV933.59+7.15 (+0.77%) ▲|GILD156.90-0.47 (-0.30%) ▼|GM85.23+1.57 (+1.88%) ▲|GOOG340.26-4.65 (-1.35%) ▼|GOOGL344.13-5.09 (-1.46%) ▼|GS899.30+8.02 (+0.90%) ▲|HD312.61+4.37 (+1.42%) ▲|HON211.78+1.28 (+0.61%) ▲|IBM233.52-0.60 (-0.26%) ▼|INTC92.34-3.03 (-3.18%) ▼|INTU326.59-3.58 (-1.08%) ▼|ISRG433.29+5.43 (+1.27%) ▲|JNJ257.34+4.06 (+1.60%) ▲|JPM342.06+6.53 (+1.95%) ▲|KO93.37+1.37 (+1.48%) ▲|LIN500.24+7.02 (+1.42%) ▲|LLY1,265.23+13.62 (+1.09%) ▲|LMT546.01+13.37 (+2.51%) ▲|LOW198.43+2.71 (+1.38%) ▲|LRCX270.92-6.55 (-2.36%) ▼|MA620.09+3.77 (+0.61%) ▲|MCD243.80+1.30 (+0.53%) ▲|MDLZ64.06+1.03 (+1.63%) ▲|MDT95.63+0.18 (+0.19%) ▲|META726.33-10.39 (-1.41%) ▼|MMM167.05+1.72 (+1.04%) ▲|MO74.86+1.02 (+1.38%) ▲|MRK147.21+2.02 (+1.39%) ▲|MS182.90+0.80 (+0.44%) ▲|MSFT535.99-3.45 (-0.64%) ▼|MU893.37-37.87 (-4.07%) ▼|NEE80.08+1.12 (+1.42%) ▲|NFLX71.06-1.56 (-2.14%) ▼|NKE37.61+0.47 (+1.27%) ▲|NOW145.95-2.63 (-1.77%) ▼|NVDA216.23-1.00 (-0.46%) ▼|ORCL131.80-2.67 (-1.99%) ▼|PEP130.37+1.99 (+1.55%) ▲|PFE29.56+0.12 (+0.41%) ▲|PG159.63+2.55 (+1.62%) ▲|PLTR194.95-5.55 (-2.77%) ▼|PM204.33+4.43 (+2.21%) ▲|QCOM174.35-4.05 (-2.27%) ▼|RTX190.95+4.00 (+2.14%) ▲|SBUX97.01+0.13 (+0.13%) ▲|SCHW93.83-0.33 (-0.35%) ▼|SO90.12+0.94 (+1.05%) ▲|SPG205.58+2.19 (+1.08%) ▲|T23.56+0.06 (+0.23%) ▲|TMO691.51-4.98 (-0.72%) ▼|TMUS158.75+1.72 (+1.10%) ▲|TSLA366.61+4.17 (+1.15%) ▲|TXN280.91+1.79 (+0.64%) ▲|UBER71.22-0.05 (-0.07%) ▼|UNH397.50-9.17 (-2.25%) ▼|UNP289.48+0.77 (+0.27%) ▲|UPS99.15+1.32 (+1.35%) ▲|USB58.62+1.23 (+2.13%) ▲|V403.07+3.32 (+0.83%) ▲|VZ44.66+0.26 (+0.57%) ▲|WFC84.08+1.33 (+1.61%) ▲|WMT118.83+0.96 (+0.81%) ▲|XOM175.92+1.24 (+0.71%) ▲|
17.3 C
New York
Friday, October 16, 2026

Tag: Pivotal

Yamo Pharmaceuticals Announces Autism Trial Registry Following Global Surge in Family Interest

More Than 6,000 Inquiries Since May; Yamo Opens a Registration Site to Help Speed Phase 3 EnrollmentNEW YORK, Oct. 9, 2026 /PRNewswire/ -- Yamo...

Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026

SHANGHAI and HONG KONG, Oct. 9, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated...

Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026

SHANGHAI and HONG KONG, Oct. 8, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated...

TVS MOTOR COMPANY TAKES ITS GLOBAL MOTORCYCLE JOURNEY TO EUROPE WITH TRIC DEBUT AT MISANO

14 racers from 12 nationalities and 4 continents headline TVS Racing's European entry following its debut at EICMA last year that reflects the company's...

Innovent Announces Phase 3 RESTORE-3 Study of SYCUME® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease

SYCUME® Significantly Improved Proptosis (Response Rate 60.4% / LS Mean Change from Baseline -1.88 mm) with Favorable Safety Profile in Participants with Inactive Thyroid...

Torngat Metals Appoints Michael McCann as CEO

To Lead the Next Phase of Development of the Strange Lake Projectas the Need Intensifies for Secure Supply of Dysprosium, Terbium, Yttrium and other...

Taiwan Showcases Integrated Pharma Supply Chain Solutions at CPHI Milan 2026 Amid Global Restructuring

MILAN, Oct. 8, 2026 /PRNewswire/ -- A news report from GeneOnline.Amid rapid restructuring in the global pharmaceutical supply chain, drugmakers around the world are...

Ribo Submits European Clinical Trial Application for Phase Ⅰ Study of INHBE-Targeting siRNA RBD3133

SUZHOU, China and MÖLNDAL, Sweden, Oct. 8, 2026 /PRNewswire/ -- Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to...

Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel

The custom digital storefront brings together Marina Bay Sands' rooms, suites and resort experiences, expanding visibility across Agoda's booking journeySINGAPORE, Oct. 8, 2026 /PRNewswire/...

Ribo Submits European Clinical Trial Application for Phase Ⅰ Study of INHBE-Targeting siRNA RBD3133

SUZHOU, China and MÖLNDAL, Sweden, Oct. 8, 2026 /PRNewswire/ -- Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to...

Ribo Submits European Clinical Trial Application for Phase Ⅰ Study of INHBE-Targeting siRNA RBD3133

SUZHOU, China and MÖLNDAL, Sweden, Oct. 7, 2026 /PRNewswire/ -- Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to...

4 Greenberg Traurig Attorneys Named to The Hollywood Reporter’s 2026 Top Music Lawyers List

ATLANTA, Oct. 7, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, LLP Shareholders Charles J. Biederman, Jess Rosen, Bobby Rosenbloum, and Charmaine D. Smith were...

Commvault Appoints Matthew Stauble as Chief Customer Officer

 Veteran customer leader joins Commvault to accelerate customer value, resilience, and growth in the AI eraTINTON FALLS, N.J., Oct. 7, 2026 /PRNewswire/ -- Commvault (NASDAQ:...

Three Scientists Honored with $250,000 Blavatnik Awards for Breakthroughs in Organic Chemistry, Gene Editing and Bioelectronics

Celebrations held at the American Museum of Natural History in New York for the Blavatnik Awards for Young Scientists' 20th anniversary gala.NEW YORK, Oct....

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPivotal